15 filings
8-K
CINC
CinCor Pharma Inc
24 Feb 23
Completion of Acquisition or Disposition of Assets
9:19am
8-K
CINC
CinCor Pharma Inc
21 Feb 23
Regulation FD Disclosure
8:51am
8-K
CINC
CinCor Pharma Inc
9 Jan 23
CinCor Pharma to be Acquired by AstraZeneca
9:06am
8-K
CINC
CinCor Pharma Inc
28 Nov 22
Regulation FD Disclosure
7:37am
8-K
CINC
CinCor Pharma Inc
8 Nov 22
Regulation FD Disclosure
6:02am
8-K
48n3sv4jdik8yzwnvgk
7 Nov 22
CinCor Pharma Appoints Michael W. Kalb, Executive Vice President and Chief Financial Officer
8:12am
8-K/A
803 qw01z5258p
4 Nov 22
Results of Operations and Financial Condition
8:09am
8-K
07qf73eutrk
3 Nov 22
CinCor Reports Third Quarter Financial Results and Provides Corporate Update
8:29am
8-K
8yygp
11 Aug 22
CinCor Pharma Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants
9:21am
8-K
e8r st1l2iytb
8 Aug 22
CinCor Reports Second Quarter Financial Results and Provides Corporate Update
7:22am
8-K
edu3gwbqdpl
8 Aug 22
Regulation FD Disclosure
7:12am
8-K
j7h7h80sx ar3
10 May 22
CinCor Reports First Quarter Financial Results and Provides Corporate Update
8:13am
8-K
38l668n i0
22 Mar 22
CinCor Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
8:28am
8-K
ith9z7xm1 67
28 Jan 22
Departure of Directors or Certain Officers
4:57pm
8-K
igr lpuh3ke
11 Jan 22
Amendments to Articles of Incorporation or Bylaws
4:06pm
- Prev
- 1
- Next